<i>IDH</i>-wildtype lower-grade diffuse gliomas: the importance of histological grade and molecular assessment for prognostic stratification
Giulia Berzero(Sorbonne Université), Marc Sanson(Centre National de la Recherche Scientifique), Susanna Ronchi(University of Insubria), Alice Laurenge(Allen Institute for Brain Science), Franck Bielle(Centre National de la Recherche Scientifique), Marine Giry(Centre National de la Recherche Scientifique), Chiara Villa(Centre National de la Recherche Scientifique), Bertrand Mathon(Sorbonne Université), Karima Mokhtari(Inserm), Erell Guillerm(Sorbonne Université), Anna Luisa Di Stefano(Hôpital Foch), Ahmed Idbaïh(Centre National de la Recherche Scientifique), Laurent Capelle(Sorbonne Université), Yannick Marie(Assistance Publique – Hôpitaux de Paris), Yohann Schmitt(Centre National de la Recherche Scientifique), Jean‐Yves Delattre(Commissariat à l'Énergie Atomique et aux Énergies Alternatives), Khê Hoang‐Xuan(Sorbonne Université)
Cited by 140
Related Papers
Glioblastoma in adults: a Society for Neuro-Oncology (SNO) and European Society of Neuro-Oncology (EANO) consensus review on current management and future directions
|Neuro-Oncology|2020|1.1k
Long-term efficacy of early versus delayed radiotherapy for low-grade astrocytoma and oligodendroglioma in adults: the EORTC 22845 randomised trial
|The Lancet|2005|1k
Lomustine and Bevacizumab in Progressive Glioblastoma
|New England Journal of Medicine|2017|994
Genome-wide association study identifies five susceptibility loci for glioma
|Nature Genetics|2009|797